Mark Baxter

So they'll shake, they'll cry, they'll emote, you know, all this stuff that was frozen inside them will start to kind of come out.

which is important as well.

And so there's this kind of body process, nervous system process, and this psychological kind of rewiring or re-reckoning with the past.

Yeah, and the two are interrelated.

So what we know is if there's a sensitized memory, so a memory that when you think about it creates a lot of disturbance and distress,

If we can desensitize that image, we find that the belief system will start to shift.

If we don't desensitize the image, the belief system stays rock solid.

So I'm worthless or I'm unlovable.

These belief systems, they can't shift unless we desensitize these frozen, deeply held, re-experienced images from the past, which is, it's a fascinating part of like how humans are kind of built.

But we've kind of found that there's this kind of process that can help.

Yeah, it's interesting.

This is still not widely known.

And there's reasons for that.

We're not allowed to advertise it and other reasons why people don't know about this.

But yeah, in 2023, the Therapeutic Goods Administration, the TGA in Australia, made a decision after lots of advocacy from different organizations in Australia that we would be allowed to provide MDMA-assisted therapy for post-traumatic stress disorder and psilocybin-assisted therapy for treatment-resistant depression.

So in the clinical research around the world, they're two of the conditions and two of the treatments that have shown initial promise in the clinical trial outcomes.

So Australian government's decided to start there with the idea potentially down the track that we will kind of open it up into other conditions and things like that.

So yeah, what many people don't know is for the last couple of years, we've been treating people in Australia for that.

And

It's work I've been doing for the last 18 months.